home / stock / ogen / ogen short
Short Information | Oragenics Inc. (NYSE:OGEN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 37,950 |
Total Actual Volume | 2,989,278 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 1,898 |
Average Short Percentage | 1.34% |
Is there a OGEN Short Squeeze or Breakout about to happen?
See the OGEN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-22-2024 | $1.06 | $1.04 | $1.06 | $1.01 | 63,348 | 228 | 0.36% |
07-19-2024 | $1.07 | $1.02 | $1.0899 | $1.01 | 93,005 | 1,228 | 1.32% |
07-18-2024 | $1.14 | $1.02 | $1.14 | $1 | 228,046 | 800 | 0.35% |
07-17-2024 | $1.14 | $1.12 | $1.14 | $1.1199 | 47,544 | 539 | 1.13% |
07-16-2024 | $1.16 | $1.13 | $1.16 | $1.12 | 59,287 | 594 | 1% |
07-15-2024 | $1.15 | $1.18 | $1.185 | $1.11 | 186,377 | 2,828 | 1.52% |
07-12-2024 | $1.15 | $1.115 | $1.16 | $1.09 | 222,665 | 4,312 | 1.94% |
07-11-2024 | $1.24 | $1.14 | $1.24 | $1.09 | 229,780 | 51 | 0.02% |
07-10-2024 | $1.09 | $1.18 | $1.21 | $1.09 | 368,727 | 884 | 0.24% |
07-09-2024 | $1.06 | $1.06 | $1.08 | $1.0201 | 208,042 | 1,138 | 0.55% |
07-08-2024 | $1.03 | $1.03 | $1.06 | $1.02 | 326,778 | 2,128 | 0.65% |
07-05-2024 | $1.04 | $1.0159 | $1.04 | $1.0159 | 33,815 | 52 | 0.15% |
07-03-2024 | $1.09 | $1.03 | $1.09 | $1.02 | 80,496 | 46 | 0.06% |
07-02-2024 | $1.04 | $1.02 | $1.04 | $1 | 49,161 | 205 | 0.42% |
07-01-2024 | $1.06 | $1.0601 | $1.09 | $1.0224 | 45,490 | 2,492 | 5.48% |
06-28-2024 | $1.01 | $1.04 | $1.055 | $1 | 57,465 | 1,079 | 1.88% |
06-27-2024 | $1.03 | $0.99 | $1.03 | $0.9701 | 159,982 | 1,895 | 1.18% |
06-26-2024 | $0.9993 | $1.01 | $1.03 | $0.98 | 133,450 | 3,906 | 2.93% |
06-25-2024 | $1.05 | $1 | $1.05 | $0.97 | 344,586 | 12,564 | 3.65% |
06-24-2024 | $1.5 | $1.305 | $1.5 | $1.25 | 51,234 | 981 | 1.91% |
News, Short Squeeze, Breakout and More Instantly...
SARASOTA, Fla., July 10, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced it has developed a new formulation for its novel neurosteroid. Oragenics’...
SARASOTA, Fla., June 27, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced it has completed a prototype of its automated intranasal device for use in concu...